Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Gynecologic Cancers
Clinical trial register · Italy

Gynecologic Cancers Trials in Italy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6812 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:19 UTC
6812
Studies in scope
all four open statuses
4098
Recruiting now
open to new participants
1015
Lead sponsors
across recruiting studies
Top sites
Bologna 2 Udine 2 Roma 2 Parma 1 Cuneo 1
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Gynecologic Cancers trials in Italy

3 of 6812 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
200
Roma
2026-03-12
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Not applicable
310
Parma, Bologna, Cuneo, Milan, Udine
2025-10-07
Recruiting
Casa di Cura Dott. Pederzoli
Observational
200
Bologna, Padova, Roma, Trieste, Udine, Peschiera del Garda
—
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-italy/condition/gynecologic-cancers

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,812 studies in total at the last sync on 20 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies listing the condition Gynecologic Cancers.

How many Gynecologic Cancers trials are recruiting in Italy?

2 of the 3 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gynecologic Cancers), 3 studies
PhaseStudiesRecruitingShare
Observational2166.7%
Not applicable1133.3%

Most active sponsors

Lead sponsors with the most studies (Gynecologic Cancers)
Lead sponsorStudiesRecruiting
Azienda Ospedaliero-Universitaria di Parma11
Casa di Cura Dott. Pederzoli11
Fondazione Policlinico Universitario Agostino Gemelli IRCCS10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.